abstract |
The present invention relates to compounds that form covalent bonds with peptidases, the compounds having, in some embodiments, broad-spectrum bioactivity. In various embodiments, the compounds act by inhibiting the bacterial type 1 signal peptidase (SPase), which is an essential protein of these bacteria. The invention also relates to pharmaceutical compositions and methods of treatment using the compounds described in the present invention. |